in brief Respiratory disorder equipment manufacturer ResMed has extended its local rollout of Objective electronic content management (ECM) software globally, it was revealed yesterday. "An Objective ...
We expect Objective’s strategy to focus on investing heavily to continue expanding its product portfolio, both organically and inorganically. Over the past decade, Objective invested heavily to adapt ...
We initiate coverage on Objective OCL with a fair value estimate of AUD 5.50 per share and a narrow economic moat rating. We view Objective as a company that has successfully carved out its niche but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback